Capecitabine and Temozolomide for Neuroendocrine Cancers

Clinical trial NCT00869050 · COMPLETED

Trial details

NCT number: NCT00869050
Sponsor: Columbia University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2005-08-01
Primary completion: 2013-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.